Hero image with Pittsburgh background pittplusme.org/study/1241

STUDY BASICS

Have you been diagnosed with prostate cancer that has spread? Have you already undergone treatment with hormone therapy and docetaxel (chemo drug)? If so, you may be eligible to participate in a study to help researchers test any good or bad effects of using the chemotherapy drug cabazitaxel (Jevtana) combined with standard of care treatment compared to people on standard of care treatment alone.


IRB:
  EA8153 - EA8153, Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel: the CHAARTED2 Trial

Age Range
AGE:   18 and up

Duration DURATION:  Up to 5 years

Location LOCATION: 
UPMC Hillman Cancer Centers
Compensation COMPENSATION: 

None

Phone Number PHONE NUMBER:
1-866-438-8230
I'M INTERESTED
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1241
OR
Phone Number PHONE NUMBER:
1-866-438-8230

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet